Email This Article

FDA Seeks Public Comment on Pharmacy Compounding Following Fungal Meningitis Cases
The Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) is inviting public comment through Jan. 18, 2013, on a framework for pharmacy compounding. The recent outbreak of fungal meningitis associated with drugs produced and sold by New England Compounding Center
To (required; use comma between emails, max Three):
Subject (required):
Your email address (required):
The message area is limited to 500 characters and allows for no html, URLs, email addresses or attachments.